Pomerantz LLP has launched an investigation into Beam Therapeutics Inc. following a press release about updated clinical trial data for BEAM-302, which showed some liver enzyme elevations despite an acceptable safety profile. The announcement led to a nearly 10% drop in Beam's stock price. The investigation is examining whether Beam and its executives engaged in securities fraud or other unlawful practices. Investors affected by the stock decline are encouraged to contact Pomerantz LLP for potential class action participation.
Beam Therapeutics Inc. is the subject of this investigation alert. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 14, 2026 03:41 WIB: Among 128 priced US health stocks, 29 rose and 99 fell. Notable movers include Sana Biotechnology Inc (SANA) at USD 2.44 with a -6.87% change and 92% buy order activity, BioNTech SE (BNTX) at USD 89.78 with a -6.32% change and 53% sell order activity, and Citius Pharmaceuticals Inc (CTXR) at USD 0.47 with a -5.60% change and 100% buy order activity.
Targa Resources Corp. announced a quarterly cash dividend of $1.25 per common share for Q3 2026, payable on November 17, 2026, to shareholders of record as of October 30, 2026. The company will release its Q3 2026 financial results before market open...
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
Pomerantz LLP has launched an investigation into Securitize Corp. and some of its officers and directors for potential securities fraud or other illegal business practices. The law firm is advising investors who suffered losses to contact them for po...
